Dustin Erin Stevenson DO (He/Him)
Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer
Remote VA Hematologist/Medical Oncologist St Cloud, Minnesota Medical Center
Join to View Full Profile
850 Fair Oaks AveSte 310Arroyo Grande, CA 93420
Phone+1 805-474-5310
Fax+1 805-474-5313
Dr. Stevenson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dustin Stevenson, DO, is an Oncologist based in Arroyo Grande, CA, with subspecialties in Gastrointestinal Cancer, Hematologic Oncology, and Thoracic Cancer. He completed his Fellowship in Hematology and Medical Oncology, and Residency in Internal Medicine at the San Antonio Uniformed Services Health Education Consortium. He is a graduate of the College of Osteopathic Medicine of the Pacific. Currently, he serves as the CEO of Dustin Stevenson DO INC. He holds experience in dealing with conditions such as amyloidosis, erythrocytosis, lynch syndrome, and myelodysplasia. He has also participated in clinical trials focused on high-risk breast cancer treatments.
Education & Training
San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 2004 - 2007- San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 2001 - 2004
College of Osteopathic Medicine of the PacificClass of 2001
Certifications & Licensure
CA State License 2011 - 2026
WA State License 2022 - 2025
TX State License 2007 - 2012
VA State License 2003 - 2008
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
National Board of Physicians and Surgeons Hematology- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Clinical Trials
- S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Press Mentions
Your Cancer Answers: Does the COVID-19 Vaccine Protect Patients with Cancer?October 30th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
